Does J9024 require prior authorization?

Yes, J9024 requires prior authorization (high confidence). At least one active policy explicitly requires prior authorization.

What is the Medicare reimbursement rate for J9024?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

Backwork Sign up free

`J9024`, Injection, atezolizumab, 5 mg and hyaluronidase-tqjs

HCPCS/CPT

Prior Authorization

Prior Auth Required

At least one active policy explicitly requires prior authorization (high confidence)

Medicare Pricing

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

Key Coverage Criteria

Coverage of injectable oncology medications is based on NCCN Compendium Categories of Evidence and Consensus (1, 2A, 2B = proven/medically necessary; 3 = unproven/not medically necessary); if NCCN is unavailable, base decisions on FDA labeling.
Coverage is provided for injectable oncology medications listed in the NCCN Compendium with Categories of Evidence and Consensus of 1, 2A, or 2B as proven and medically necessary; categories with 3 are unproven and not medically necessary.
Coverage is provided for injectable oncology medications listed in the NCCN Compendium with Categories of Evidence and Consensus of 1, 2A, or 2B as proven and medically necessary; Category 3 is unproven and not medically necessary. If NCCN has no compendium, coverage determinations are based on FDA labeling.

13 Active Policies

ARKBLUE-ATEZOLIZUMAB-AND-ATEZOLIZUMAB-WITH-HYALURONIDASE-89E4D3733B, Atezolizumab and Atezolizumab with Hyaluronidase (e.g., Tecentriq and Tecentriq Hybreza)

FLORIDA_BLUE-FLBLUE-TECENTRIQTM-ATEZOLIZUMAB-AND-TECENTRIQ-HYBREZATM-313D807C25, Tecentriq (atezolizumab) and Tecentriq Hybreza

MODA-MODA-MPS-TECENTRIQ-SQ-8C12E1EC87, Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs)

HEALTHNET_OR-HNOR-ATEZOLIZUMAB-TECENTRIQ-ATEZOLIZUMAB-HYALURONIDASE-TECENT-85F8D5673E, Atezolizumab (Tecentriq), Atezolizumab-Hyaluronidase (Tecentriq Hybreza); CP.PHAR.235

IBX-COMMERCIAL-08-01-69F-4E1DD6DA7D, Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)

IBX-MEDICARE-ADVANTAGE-MA08-127F-726AC2C276, Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)

EVICORE-HPLAN-CIGNA-729A536F50C8, Q3 - 2026 Cigna MedOnc Master Drug List.pdf

SUREST-POL-SUREST-oncology-medication-clinical-coverage-policy, Oncology Medication Clinical Coverage

EVICORE-HPLAN-HEALTH_PARTNERS_PLANS-4BC80209CCC5, Q3 - 2026 Jefferson Health Plans MedOnc Master Drug List

AMERIHEALTH-COMMERCIAL-08-01-69F-3EEA363016, Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)

AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-127F-7F5FC3D7DA, Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)

UHC-POL-oncology-medication-clinical-coverage-policy, Oncology Medication Clinical Coverage

UMR-POL-UMR-oncology-medication-clinical-coverage-policy, Oncology Medication Clinical Coverage

Have a follow-up question?

Ask Backwork about documentation requirements, denial risks, or coverage in your state.

Ask Backwork about J9024 Sign up free

J9024, Injection, atezolizumab, 5 mg and hyaluronidase-tqjs